Hussain Alizadeh
Overview
Explore the profile of Hussain Alizadeh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
61
Citations
380
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vida L, Horvath B, Egyed M, Kajtar B, Alizadeh H
Hematol Rep
. 2025 Jan;
17(1.
PMID: 39846605
T-cell prolymphocytic leukemia (T-PLL) is a rare mature T-cell lymphoma that is usually associated with poor prognosis and short overall survival. We present a case of a 61-year-old woman presenting...
2.
3.
Batar P, Alizadeh H, Rokszin G, Abonyi-Toth Z, Demeter J
Pathol Oncol Res
. 2024 Apr;
30:1611758.
PMID: 38576767
[This corrects the article DOI: 10.3389/pore.2024.1611497.].
4.
Batar P, Alizadeh H, Rokszin G, Abonyi-Toth Z, Demeter J
Pathol Oncol Res
. 2024 Mar;
30:1611497.
PMID: 38444749
This study aimed to provide real-world evidence on the characteristics, treatment patterns, and outcomes of patients with chronic myeloid leukemia (CML) receiving tyrosine kinase inhibitor (TKI) treatment in Hungary between...
5.
Nemeth M, Muhl D, Csontos C, Nagy A, Alizadeh H, Szakacs Z
Biomedicines
. 2023 Sep;
11(9).
PMID: 37760842
The role of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has been implicated in the pathogenesis of acquired hemophilia A (AHA). The aim of this study is to report our case...
6.
Baliko A, Szakacs Z, Kajtar B, Ritter Z, Gyenesei A, Farkas N, et al.
Front Oncol
. 2023 Sep;
13:1224733.
PMID: 37746254
Background: The clinical and genetic heterogeneity of diffuse large B-cell lymphoma (DLBCL) presents distinct challenges in predicting response to therapy and overall prognosis. The main objective of this study was...
7.
Toth T, Alizadeh H, Polgar B, Csalodi R, Reglodi D, Tamas A
Int J Mol Sci
. 2023 Jul;
24(13).
PMID: 37445974
Pituitary adenylate cyclase-activating polypeptide (PACAP) is a multifunctional neuropeptide with well-known anti-inflammatory, antioxidant, antitumor, and immunomodulatory effects. PACAP regulates the production of various proinflammatory factors and may influence the complex...
8.
Nagy A, Batai B, Kiss L, Grof S, Kiraly P, Jona A, et al.
J Intern Med
. 2023 Jun;
294(3):295-313.
PMID: 37259686
Background: Recent genomic studies revealed enhancer of zeste homolog 2 (EZH2) gain-of-function mutations, representing novel therapeutic targets in follicular lymphoma (FL) in around one quarter of patients. However, these analyses...
9.
Kotmayer L, Laszlo T, Mikala G, Kiss R, Levay L, Hegyi L, et al.
Int J Mol Sci
. 2023 Mar;
24(6).
PMID: 36982875
The oral, highly selective Bcl2 inhibitor venetoclax has substantially improved the therapeutic landscape of chronic lymphocytic leukemia (CLL). Despite the remarkable response rates in patients with relapsed/refractory (R/R) disease, acquired...
10.
Pal S, Reger B, Alizadeh H, Szomor A, Vereczkei A, Kiss T, et al.
Heliyon
. 2023 Mar;
9(3):e14391.
PMID: 36919084
The novel coronavirus (SARS-CoV-2) outbreak exerted a serious effect on healthcare. Between 1st of January and May 31, 2020 due to the special regulations in Hungary, the number of reported...